Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities:
Net loss	$ (12,671,812)	$ (7,208,038)
Adjustment to reconcile net loss to net cash used in operating activities:
Stock based compensation	1,267,320	378,607
Changes in operating assets and liabilities:
Prepaid assets	519,816	(261,204)
Accounts payable	501,877	181,307
Net cash used in operating activities	(10,382,799)	(6,909,328)
Cash flows from investing activities:
Purchases of property and equipment	(293,243)
Net cash used in investing activities	(293,243)
Cash flows from financing activities:
Proceeds from issuance of common stock, net of issuance costs	24,280,283
Proceeds from issuance of preferred stock		7,198,226
Net cash provided by financing activities	24,280,283	7,198,226
Effect of exchange rate changes on cash and cash equivalents	(81,286)
Net change in cash and cash equivalents	13,522,955	288,898
Cash and cash equivalents at beginning of period	28,094,936	10,261,671
Cash and cash equivalents at end of period	41,617,891	10,550,569
Supplemental disclosure of non-cash investing and financing activities:
Accrued offering costs		81,153
Accrued dividend		768,876
Cashless exercise of warrants	506
Issuance of common stock for accrued research and development expense	1,132,013
Purchases of property and equipment included in accounts payable	$ 652,122